Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.2B bought by 555 insiders at 344 companies
- $9.7B sold by 671 insiders outside a trading plan
- $4.8B sold by 992 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$161M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Joseph M Rutledge VP, CAONDSNNordson CorporationSale$212K 684 shares at $309.38 24% of stakeTraded Sep 15 Filed Sep 16
-
Michael John Callahan Chief Administrative OfficerRIVNRivian Automotive, Inc.Planned sale$244K 15,000 shares at $16.29 1.5% of stakeTraded Sep 11 Filed Sep 16
-
Christopher Thomas Giordano CEOTENXTenax Therapeutics, Inc.Buy$20K 10,850 shares at $1.85 +96% to stakeTraded Sep 11–15 Filed Sep 15
-
Matthew J Murphy CEOMRVLMarvell Technology, Inc.Planned sale$1.7M 7,500 shares at $223.39 1% of stakeTraded Sep 15 Filed Sep 15
-
Thomas R Staab II CFOTENXTenax Therapeutics, Inc.Buy$11K 5,675 shares at $1.94 +57% to stakeTraded Sep 11 Filed Sep 15
-
Amber Russell EVP, RefiningDKDelek US Holdings, Inc.Sale$407K 5,392 shares at $75.50 13% of stakeTraded Sep 11 Filed Sep 15
-
Lauren Rusckowski Duprey Chief Transformation OfficerTAKTakeda Pharmaceutical Company LimitedSale$640K 34,535 shares at $18.54 15% of stakeTraded Sep 14 Filed Sep 15
-
Jaymes Winters CEOSTISolidion Technology, Inc.Buy$6,996 984 shares at $7.11 +26% to stakeTraded Sep 9 Filed Sep 15
-
Amir F Heshmatpour CEONTHINeOnc Technologies Holdings, Inc.Buy$175K 50,000 shares at $3.50 +1.6% to stakeTraded Sep 14–15 Filed Sep 15
-
Thomas C Chen CEONTHINeOnc Technologies Holdings, Inc.Buy$40K 10,798 shares at $3.70 +79% to stakeTraded Sep 11–14 Filed Sep 15
-
Keithly Garnett CFONTHINeOnc Technologies Holdings, Inc.Buy$1,001 257 shares at $3.89 +0.1% to stakeTraded Sep 14 Filed Sep 15
-
Wesley R Edens CEONFENew Fortress Energy Inc.Buy— 28,313 shares +3% to stakeTraded Sep 11 Filed Sep 15
-
Sumedh S Thakar CEOQLYSQualys, Inc.Planned sale$544K 3,200 shares at $170.05 1.7% of stakeTraded Sep 14 Filed Sep 15
-
Peter Trizzino President, Global SalesDELLDell Technologies Inc.Sale$21.1M 37,735 shares at $560.16 35% of stakeTraded Sep 11 Filed Sep 15
-
Richard J Rothberg General Counsel & SecretaryDELLDell Technologies Inc.Sale$3.3M 6,000 shares at $547.56 4.2% of stakeTraded Sep 11 Filed Sep 15
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.4M 20,000 shares at $220.44 0.3% of stakeTraded Sep 11–14 Filed Sep 15
-
Neto Bruno Guicardi Pres. of N. Am. and Europe OpsCINTCI&T IncBuy$18K 5,489 shares at $3.21 +6.4% to stakeTraded Sep 10–11 Filed Sep 15
-
Vikram Verghese CFOHTFLHeartflow, Inc.Planned sale$1.8M 34,975 shares at $50.08 16% of stakeTraded Sep 11–15 Filed Sep 15
-
Gabriel M.i. Mecklenburg ChairHNGEHinge Health, Inc.Planned sale$14M 150,000 shares at $93.22 100% of stakeTraded Sep 14 Filed Sep 15
-
Joana Goncalves Chief Medical OfficerORKAOruka Therapeutics, Inc.Planned sale$644K 7,000 shares at $91.93 18% of stakeTraded Sep 15 Filed Sep 15
-
Arjun Agarwal Senior Vice President, FinanceORKAOruka Therapeutics, Inc.Planned sale$872K 9,459 shares at $92.23 38% of stakeTraded Sep 11 Filed Sep 15
-
Laura Fuentes See RemarksHLTHilton Worldwide Holdings Inc.Sale$2.3M 7,289 shares at $309.81 18% of stakeTraded Sep 14 Filed Sep 15
-
Yuen Wupen President, Global Bus. UnitsLITELumentum Holdings Inc.Planned sale$1.3M 1,500 shares at $882.69 1.3% of stakeTraded Sep 11–15 Filed Sep 15
-
Sean Chihhsiang Chen COOAMBQAmbiq Micro, Inc.Planned sale$902K 15,000 shares at $60.14 11% of stakeTraded Sep 14 Filed Sep 15
-
Theodore Alan Huizenga SVP, Chief Accounting OfficerRAREUltragenyx Pharmaceutical Inc.Planned sale$17K 1,283 shares at $13.57 1.9% of stakeTraded Sep 15 Filed Sep 15
-
Fumihide Esaka CEOAMBQAmbiq Micro, Inc.Planned sale$4M 63,500 shares at $62.70 12% of stakeTraded Sep 11–15 Filed Sep 15
-
Margaret Tooth CEOTRUPTrupanion, Inc.Planned sale$25K 1,000 shares at $25.00 0.5% of stakeTraded Sep 11 Filed Sep 15
-
Stephen C. Chen General CounselDUOLDuolingo, Inc.Planned sale$1.2M 8,072 shares at $149.33 16% of stakeTraded Sep 14 Filed Sep 15
-
Meghan Bartholomew Sr EVP Co-Head Radian GuarantyRDNRadian Group Inc.Planned sale$281K 7,812 shares at $35.94 17% of stakeTraded Sep 14 Filed Sep 15
-
Antonio F Neri CEOHPEHewlett Packard Enterprise CompanyPlanned sale$15.1M 250,000 shares at $60.44 15% of stakeTraded Sep 11 Filed Sep 15
-
Jill Hazelbaker See RemarksUBERUber Technologies Inc.Sale$2M 28,170 shares at $71.31 16% of stakeTraded Sep 11 Filed Sep 15
-
Ashraf Alkarmi CEODBXDropbox, Inc.Planned sale$1M 28,800 shares at $35.54 2.8% of stakeTraded Sep 11 Filed Sep 15
-
Amy Hood CFOMSFTMicrosoft CorporationPlanned sale$20.8M 41,674 shares at $498.27 7.2% of stakeTraded Sep 14 Filed Sep 15
-
Stephen Michael Kelsey See RemarksRVMDRevolution Medicines, Inc.Planned sale$18.7M 92,531 shares at $202.36 24% of stakeTraded Sep 11 Filed Sep 15
-
David Martin Afdahl COOIBEXIBEX LimitedPlanned sale$433K 10,819 shares at $40.07 7.7% of stakeTraded Sep 14 Filed Sep 15
-
Henry W Kilmer VP of Network StrategyCCOICogent Communications Holdings, Inc.Sale$22K 2,400 shares at $9.21 6.2% of stakeTraded Sep 15 Filed Sep 15
-
Michael F Montoya Chief Technology Ops OfficerFFIVF5, Inc.Planned sale$1.8M 4,426 shares at $410.16 77% of stakeTraded Sep 14 Filed Sep 15
-
Paul Joseph Inson Chief People OfficerIBEXIBEX LimitedPlanned sale$91K 2,274 shares at $40.00 7.1% of stakeTraded Sep 14 Filed Sep 15
-
John Anthony Maddison Chief Product Mkting OfficerFFIVF5, Inc.Planned sale$83K 204 shares at $406.24 15% of stakeTraded Sep 14 Filed Sep 15
-
James A. Christy EVP, CRO of Provident BankPFSProvident Financial Services, IncSale$70K 3,000 shares at $23.36 6.5% of stakeTraded Sep 14 Filed Sep 15
-
Robert A Frist Jr. CEOHSTMHealthStream, Inc.Sale$4.3M 144,068 shares at $29.50 3.6% of stakeTraded Sep 14 Filed Sep 15
-
Paul C Joseph EVP - Global SalesAKAMAkamai Technologies, Inc.Planned sale$327K 3,100 shares at $105.63 9.8% of stakeTraded Sep 15 Filed Sep 15
-
Jeremiah Nienhuis Head of Strat. & Product Ops.LVWRLiveWire Group, Inc.Sale$12K 10,732 shares at $1.15 8.8% of stakeTraded Sep 3 Filed Sep 15
-
James Grant Conroy CEOROSTRoss Stores, Inc.Sale$11.3M 49,205 shares at $229.48 27% of stakeTraded Sep 14 Filed Sep 15
-
Tomer Weingarten CEOSSentinelOne, Inc.Planned sale$2.3M 114,890 shares at $19.89 6.2% of stakeTraded Sep 11 Filed Sep 15
-
Matthew Albence Senior VP, Client RelationsGEOGeo Group Inc (The)Sale$371K 11,797 shares at $31.46 12% of stakeTraded Sep 11 Filed Sep 15
-
Milton C Ault III ChairGPUSHyperscale Data, Inc.Buy$1,212 6,600 shares at $0.1800 +0.8% to stakeTraded Sep 11–14 Filed Sep 15
-
Robert I Blum CEOCYTKCytokinetics, IncorporatedPlanned sale$7.3M 105,426 shares at $69.62Traded Sep 14–15 Filed Sep 15
-
Stephen C Brinkley President, OperationsROSTRoss Stores, Inc.Sale$1.5M 6,424 shares at $229.66 11% of stakeTraded Sep 14 Filed Sep 15
-
Scott B. Flaherty CFOWLFCWillis Lease Finance CorporationSale$1.6M 30,000 shares at $54.45 12% of stakeTraded Sep 11–15 Filed Sep 15
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.